222

GENIANS

No trades
See on Supercharts
Next report date
Report period
Q1 2024
EPS estimate
Revenue estimate
Market capitalization
‪97.98 B‬KRW
‪6.25 B‬KRW
‪42.89 B‬KRW
‪4.44 M‬
Beta (1Y)
0.79

About GENIANS

CEO
Dong-Bum Lee
Headquarters
Anyang-si
Employees (FY)
188
Founded
2005
ISIN
KR7263860009
FIGI
BBG00H0D6H36
GENIANS, INC. engages in developing system software. It offers prepackaged software. The company was founded on January 6, 2005 and is headquartered in Anyang-si, South Korea.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 263860 is 11280 KRW — it has decreased by 0.18% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange GENIANS stocks are traded under the ticker 263860.
GENIANS is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.
263860 stock is 1.51% volatile and has beta coefficient of 0.79. Check out the list of the most volatile stocks — is GENIANS there?
263860 earnings for the last quarter are 525.00 KRW per share, whereas the estimation was 20.00 KRW resulting in a ‪2.53 K‬% surprise. The estimated earnings for the next quarter are 248.00 KRW per share. See more details about GENIANS earnings.
GENIANS revenue for the last quarter amounts to ‪7.70 B‬ KRW despite the estimated figure of ‪8.20 B‬ KRW. In the next quarter revenue is expected to reach ‪17.40 B‬ KRW.
Yes, you can track GENIANS financials in yearly and quarterly reports right on TradingView.
263860 stock has fallen by 3.34% compared to the previous week, the month change is a 15.19% fall, over the last year GENIANS has showed a 4.93% increase.
263860 net income for the last quarter is ‪2.78 B‬ KRW, while the quarter before that showed ‪662.78 M‬ KRW of net income which accounts for 318.90% change. Track more GENIANS financial stats to get the full picture.
Today GENIANS has the market capitalization of ‪97.48 B‬, it has decreased by 1.30% over the last week.
Yes, 263860 dividends are paid annually. The last dividend per share was 200.00 KRW. As of today, Dividend Yield (TTM)% is 1.77%. Tracking GENIANS dividends might help you take more informed decisions.
GENIANS dividend yield was 1.59% in 2023, and payout ratio reached 27.97%. The year before the numbers were 1.82% and 18.52% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 263860 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENIANS stock right from TradingView charts — choose your broker and connect to your account.
263860 reached its all-time high on Jun 13, 2023 with the price of 17640 KRW, and its all-time low was 2370 KRW and was reached on Mar 20, 2020.
See other stocks reaching their highest and lowest prices.
As of Apr 26, 2024, the company has 188.00 employees. See our rating of the largest employees — is GENIANS on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GENIANS technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GENIANS stock shows the sell signal. See more of GENIANS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GENIANS EBITDA is ‪7.05 B‬ KRW, and current EBITDA margin is 16.43%. See more stats in GENIANS financial statements.